サマリー

副鼻腔炎薬の世界市場 2023-2027
Technavioは副鼻腔炎薬市場を監視しており、2023-2027年の間に801.39百万ドル、予測期間中にCAGR6.23%で加速して成長すると予測されています。当レポートでは、副鼻腔炎治療薬市場の全体分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。副鼻腔炎の有病率の上昇、副鼻腔炎治療に関する人々の意識の高まり、M&Aの増加などが市場を牽引しています。
Technavioの副鼻腔炎治療薬市場は以下のようにセグメント化されています。
製品別
- ステロイド点鼻薬
- 抗生物質
- 充血除去剤
- その他の薬剤
疾患別
- 急性副鼻腔炎
- 慢性副鼻腔炎
- 亜急性副鼻腔炎
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、大手企業による研究開発への投資の増加が、今後数年間の副鼻腔炎治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、生物製剤の登場と技術的進歩は、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータの研究、合成、主要パラメータの分析による総括の方法により、市場の詳細な図を提示します。副鼻腔炎薬市場に関する当レポートは、以下の分野を対象としています。
- 副鼻腔炎治療薬市場のサイジング
- 副鼻腔炎治療薬市場の予測
- 副鼻腔炎治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie社、Alembic Pharmaceuticals社、Aurobindo Pharma社、Bayer AG、Bionpharma社、CHIESI Farmaceutici SpA、Cipla社、Dr Reddys Laboratories Ltd.、Fresenius SE and Co., Ltd.を含むいくつかの主要副鼻腔炎の薬のベンダーについての詳細分析を提供します。KGaA、GlaxoSmithKline Plc、Hikma Pharmaceuticals Plc、Johnson and Johnson、Merck and Co.Inc.、ネオファーマ株式会社、Novartis AG、Pfizer Inc.、Sanofi SA、Sun Pharmaceutical Industries Ltd.、Teligent Inc、およびTeva Pharmaceutical Industries Ltd.である。また、副鼻腔炎薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/sinusitis-drugs-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global sinusitis drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global sinusitis drugs market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Disease type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Steroid nasal sprays - Market size and forecast 2022-2027
o Exhibit 34: Chart on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
o 6.4 Antibiotics - Market size and forecast 2022-2027
o Exhibit 38: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
o 6.5 Decongestants - Market size and forecast 2022-2027
o Exhibit 42: Chart on Decongestants - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Decongestants - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Decongestants - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Decongestants - Year-over-year growth 2022-2027 (%)
o 6.6 Other drugs - Market size and forecast 2022-2027
o Exhibit 46: Chart on Other drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Other drugs - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Other drugs - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Other drugs - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Product
o Exhibit 50: Market opportunity by Product ($ million)
• 7 Market Segmentation by Disease Type
o 7.1 Market segments
o Exhibit 51: Chart on Disease Type - Market share 2022-2027 (%)
o Exhibit 52: Data Table on Disease Type - Market share 2022-2027 (%)
o 7.2 Comparison by Disease Type
o Exhibit 53: Chart on Comparison by Disease Type
o Exhibit 54: Data Table on Comparison by Disease Type
o 7.3 Acute sinusitis - Market size and forecast 2022-2027
o Exhibit 55: Chart on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Acute sinusitis - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Acute sinusitis - Year-over-year growth 2022-2027 (%)
o 7.4 Chronic sinusitis - Market size and forecast 2022-2027
o Exhibit 59: Chart on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
o 7.5 Sub-acute sinusitis - Market size and forecast 2022-2027
o Exhibit 63: Chart on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Disease Type
o Exhibit 67: Market opportunity by Disease Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 69: Chart on Market share by geography 2022-2027 (%)
o Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 71: Chart on Geographic comparison
o Exhibit 72: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 France - Market size and forecast 2022-2027
o Exhibit 105: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 109: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 110: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 112: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 113: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 114: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 115: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 116: AbbVie Inc. - Overview
o Exhibit 117: AbbVie Inc. - Product / Service
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 Alembic Pharmaceuticals Ltd.
o Exhibit 119: Alembic Pharmaceuticals Ltd. - Overview
o Exhibit 120: Alembic Pharmaceuticals Ltd. - Product / Service
o Exhibit 121: Alembic Pharmaceuticals Ltd. - Key offerings
o 12.5 Bayer AG
o Exhibit 122: Bayer AG - Overview
o Exhibit 123: Bayer AG - Business segments
o Exhibit 124: Bayer AG - Key offerings
o Exhibit 125: Bayer AG - Segment focus
o 12.6 Dr Reddys Laboratories Ltd.
o Exhibit 126: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 127: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 128: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 129: Dr Reddys Laboratories Ltd. - Segment focus
o 12.7 Fresenius SE and Co. KGaA
o Exhibit 130: Fresenius SE and Co. KGaA - Overview
o Exhibit 131: Fresenius SE and Co. KGaA - Business segments
o Exhibit 132: Fresenius SE and Co. KGaA - Key news
o Exhibit 133: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 134: Fresenius SE and Co. KGaA - Segment focus
o 12.8 GlaxoSmithKline Plc
o Exhibit 135: GlaxoSmithKline Plc - Overview
o Exhibit 136: GlaxoSmithKline Plc - Business segments
o Exhibit 137: GlaxoSmithKline Plc - Key offerings
o Exhibit 138: GlaxoSmithKline Plc - Segment focus
o 12.9 Hikma Pharmaceuticals Plc
o Exhibit 139: Hikma Pharmaceuticals Plc - Overview
o Exhibit 140: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 141: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 142: Hikma Pharmaceuticals Plc - Segment focus
o 12.10 Johnson and Johnson
o Exhibit 143: Johnson and Johnson - Overview
o Exhibit 144: Johnson and Johnson - Business segments
o Exhibit 145: Johnson and Johnson - Key news
o Exhibit 146: Johnson and Johnson - Key offerings
o Exhibit 147: Johnson and Johnson - Segment focus
o 12.11 Merck and Co. Inc.
o Exhibit 148: Merck and Co. Inc. - Overview
o Exhibit 149: Merck and Co. Inc. - Business segments
o Exhibit 150: Merck and Co. Inc. - Key news
o Exhibit 151: Merck and Co. Inc. - Key offerings
o Exhibit 152: Merck and Co. Inc. - Segment focus
o 12.12 Neopharma Corp.
o Exhibit 153: Neopharma Corp. - Overview
o Exhibit 154: Neopharma Corp. - Product / Service
o Exhibit 155: Neopharma Corp. - Key news
o Exhibit 156: Neopharma Corp. - Key offerings
o 12.13 Novartis AG
o Exhibit 157: Novartis AG - Overview
o Exhibit 158: Novartis AG - Business segments
o Exhibit 159: Novartis AG - Key offerings
o Exhibit 160: Novartis AG - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 161: Pfizer Inc. - Overview
o Exhibit 162: Pfizer Inc. - Product / Service
o Exhibit 163: Pfizer Inc. - Key news
o Exhibit 164: Pfizer Inc. - Key offerings
o 12.15 Sanofi SA
o Exhibit 165: Sanofi SA - Overview
o Exhibit 166: Sanofi SA - Business segments
o Exhibit 167: Sanofi SA - Key news
o Exhibit 168: Sanofi SA - Key offerings
o Exhibit 169: Sanofi SA - Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 170: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 171: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 172: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global sinusitis drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Steroid nasal sprays - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Steroid nasal sprays - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Decongestants - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Decongestants - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Decongestants - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Decongestants - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Other drugs - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Other drugs - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Other drugs - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Other drugs - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Product ($ million)
Exhibits51: Chart on Disease Type - Market share 2022-2027 (%)
Exhibits52: Data Table on Disease Type - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Disease Type
Exhibits54: Data Table on Comparison by Disease Type
Exhibits55: Chart on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Acute sinusitis - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Acute sinusitis - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Acute sinusitis - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Chronic sinusitis - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Chronic sinusitis - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Sub-acute sinusitis - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Sub-acute sinusitis - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Disease Type ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share by geography 2022-2027 (%)
Exhibits70: Data Table on Market share by geography 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity by geography ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: AbbVie Inc. - Overview
Exhibits117: AbbVie Inc. - Product / Service
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Alembic Pharmaceuticals Ltd. - Overview
Exhibits120: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibits121: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibits122: Bayer AG - Overview
Exhibits123: Bayer AG - Business segments
Exhibits124: Bayer AG - Key offerings
Exhibits125: Bayer AG - Segment focus
Exhibits126: Dr Reddys Laboratories Ltd. - Overview
Exhibits127: Dr Reddys Laboratories Ltd. - Business segments
Exhibits128: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits129: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits130: Fresenius SE and Co. KGaA - Overview
Exhibits131: Fresenius SE and Co. KGaA - Business segments
Exhibits132: Fresenius SE and Co. KGaA - Key news
Exhibits133: Fresenius SE and Co. KGaA - Key offerings
Exhibits134: Fresenius SE and Co. KGaA - Segment focus
Exhibits135: GlaxoSmithKline Plc - Overview
Exhibits136: GlaxoSmithKline Plc - Business segments
Exhibits137: GlaxoSmithKline Plc - Key offerings
Exhibits138: GlaxoSmithKline Plc - Segment focus
Exhibits139: Hikma Pharmaceuticals Plc - Overview
Exhibits140: Hikma Pharmaceuticals Plc - Business segments
Exhibits141: Hikma Pharmaceuticals Plc - Key offerings
Exhibits142: Hikma Pharmaceuticals Plc - Segment focus
Exhibits143: Johnson and Johnson - Overview
Exhibits144: Johnson and Johnson - Business segments
Exhibits145: Johnson and Johnson - Key news
Exhibits146: Johnson and Johnson - Key offerings
Exhibits147: Johnson and Johnson - Segment focus
Exhibits148: Merck and Co. Inc. - Overview
Exhibits149: Merck and Co. Inc. - Business segments
Exhibits150: Merck and Co. Inc. - Key news
Exhibits151: Merck and Co. Inc. - Key offerings
Exhibits152: Merck and Co. Inc. - Segment focus
Exhibits153: Neopharma Corp. - Overview
Exhibits154: Neopharma Corp. - Product / Service
Exhibits155: Neopharma Corp. - Key news
Exhibits156: Neopharma Corp. - Key offerings
Exhibits157: Novartis AG - Overview
Exhibits158: Novartis AG - Business segments
Exhibits159: Novartis AG - Key offerings
Exhibits160: Novartis AG - Segment focus
Exhibits161: Pfizer Inc. - Overview
Exhibits162: Pfizer Inc. - Product / Service
Exhibits163: Pfizer Inc. - Key news
Exhibits164: Pfizer Inc. - Key offerings
Exhibits165: Sanofi SA - Overview
Exhibits166: Sanofi SA - Business segments
Exhibits167: Sanofi SA - Key news
Exhibits168: Sanofi SA - Key offerings
Exhibits169: Sanofi SA - Segment focus
Exhibits170: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits171: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits172: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits173: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits174: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits175: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits176: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits177: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations